4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-031670
President and CEO sold 19,488 shares at an average $8.41 ($163,893)
- President and CEO acquired 43,028 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KANE MATTHEW R. · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 1 in the form | +21,514 | $0.04 | $861 | 1,999,732 | D |
| 2021-05-07 | Sale : show line 2 in the form | −9,742 | $8.57 | $83,489 | 1,989,990 | D |
| 2021-05-10 | Exercise or conversion : show line 3 in the form | +21,514 | $0.04 | $861 | 2,011,504 | D |
| 2021-05-10 | Sale : show line 4 in the form | −9,746 | $8.25 | $80,405 | 2,001,758 | D |
| Open-market sales · 19,488 sh · avg $8.41 · $163,893 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) | −21,514 | 43,028 | D |
| 2021-05-10 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) | −21,514 | 21,514 | D |
Loading xslF345X03/doc4.xml…